Broad-range amplification of bacterial DNA from clinical specimens has proved useful for the diagnosis of various bacterial infections, especially during antimicrobial treatment of the patient. Optimal sample processing protocols for diagnostic broad-range bacterial PCR should release DNA from an array of target organisms with equal efficiencies and wash out inhibitory factors from various sample types without introducing bacterial DNA contamination to the amplification reaction. In the present study, two physical cell wall disintegration methods, bead beating and sonication, for enhanced detection of organisms with difficult-to-lyse cell walls were studied. The analytical sensitivities of several commercially available DNA purification kits, which were used with and without additional cell disintegration steps, were compared by using dilution series of model bacteria. Selected purification methods were used to process routine clinical specimens in parallel with the standard phenol-ether DNA extraction, and the results obtained by bacterial PCR and sequencing with the two template preparations were compared. The method with the DNA isolation kit with the lowest detection limits from the bacterial suspensions (Masterpure) did not prove to be superior to the standard method when the two methods were applied to 69 clinical specimens. For another set of 68 clinical specimens, DNA purified with a glass fiber filter column (High Pure) with an additional sonication step yielded results well in accord with those obtained by the standard method. Furthermore, bacterial DNA was detected in four samples that remained PCR negative by the standard method, and three of these contained DNA from gram-positive pathogens. Three samples were positive by the standard method only, indicating the limitations of applying any single method to all samples.
Direct amplification of bacterial DNA from clinical specimens with broad-range primers provides an alternative approach to the recognition of pathogens infecting normally sterile body compartments. In comparing the molecular diagnosis obtained by broad-range bacterial PCR and partial sequencing of the amplicon to the results of routine bacterial cultures, we found 83% overall agreement for a set of 536 clinical specimens from hospitalized patients (7) . The molecular approach proved superior to culture during antimicrobial treatment of the patient and in detection of bacteria with unusual growth requirements. A major drawback of the molecular method in comparison to bacterial culture was the difficulty in detecting species with gram-positive cell walls and mycobacteria. This was associated with problems in breaking bacterial cell walls and releasing bacterial DNA for amplification when standard phenol-ether DNA extraction was used. This finding led us to search for better methods to prepare the clinical specimens for broad-range bacterial PCR assay.
In general, an optimal sample processing method should concentrate the DNA, especially that derived from the target organism, and wash out inhibitory factors commonly present in biological fluids. To be applicable for routine diagnostic use, the process should be suitable for use with an array of clinical specimens, simple or preferably at least semiautomatic, reproducible, and safe for the staff handling the specimens. Furthermore, design of the process should prevent cross-contamination between the samples; i.e., samples with large amounts of target microbial cells or their nucleic acids should not contaminate other specimens in the batch.
In contrast to species-specific PCR assays, the possible target organisms of a clinical broad-range bacterial PCR test can be highly variable in their capability to resist chemical and physical treatments. In other words, an optimal sample preparation procedure should efficiently break very resistant bacterial cell walls, like those of streptococci and mycobacteria, without being too harsh for the DNA released from cells that are easily lysed. Another aspect specific for broad-range bacterial PCR is the danger of introducing bacterial DNA from the reagents used in various phases of sample processing and amplification (9) , which may result in false-positive PCR results. Elimination of this background bacterial DNA from the reactions has proved very difficult (1). Thus, aiming at maximal analytical sensitivity in the broad-range bacterial PCR assay may eventually result in impaired clinical performance of the test in diagnosing true infectious conditions.
In the study described here we studied the use of bead beating and sonication to enhance the lysis of bacterial cell walls prior to standard DNA extraction and 23S ribosomal DNA (rDNA)-targeted PCR. These lysis methods were then combined with some DNA purification protocols available in kit format, and the analytical sensitivities were compared by using dilution series of some model bacteria. Finally, selected processing methods were applied to clinical specimens in parallel with the previously used sample preparation procedures, and the results obtained by bacterial PCR and sequencing were evaluated.
Clinical specimens. A total of 137 clinical specimens sent to our laboratory for routine bacterial PCR were divided in two. One half of each specimen was processed by the routine proteinase K-phenol-ether protocol (7) , and the other half was processed by one of the selected test protocols, i.e., with the Masterpure kit (69 samples) or the High Pure kit with an additional 5-min sonication step after the lysis buffer-proteinase K treatment (68 samples). In the case of the liquid samples, two 1-ml aliquots were concentrated by centrifugation (8,000 ϫ g, 5 min) and 800 l of the supernatant was removed from each tube. The remaining 200 l was used for DNA isolation by the standard method (aliquot 1) or one of the test methods (aliquot 2). Apart from the additional sonication step in the High Pure protocol, the kits were used according to the manufacturers' instructions.
The 23S rDNA-targeted PCR described above was used to screen for the presence of bacteria in the samples. The bacterial DNA present in a 23S rDNA PCR-positive sample was identified by sequencing the 16S and/or 23S rDNA by our routine laboratory procedure (7) . The 16S rDNA was preferably used for sequencing, and 23S rDNA was sequenced if sequencing of 16S rDNA failed. The 16S rDNA PCR primers and conditions have been described previously (4) .
The PCR product was purified by use of a GFX PCR and Gel Band Purification kit (Amersham Pharmacia Biotech Inc., Piscataway, N.J.). Eleven microliters of the purified product was sequenced by use of the ABI Prism DNA sequencing kit, Big Dye Terminator Cycle Sequencing (version 2.0 or 3.0), and ABI Prism 310 genetic analyzer (Applied Biosystems). Sequencing primer 533f targets bases 515 to 533 in the bacterial 16S rDNA sequence (Escherichia coli numbering), and primer JJ04 targets bases 1601 to 1629 in the bacterial 23S rDNA sequence (4) . Additional sequencing primers (3) were used if they were considered necessary for clinical purposes. Sequence comparisons were done by using an in-house algorithm in a local database (4) and the FastA program (5) in the European Molecular Biology Laboratory (EMBL) prokaryote database (8) .
RESULTS
More than 200,000 CFU of S. pyogenes in a sample was required to yield a visible PCR product after standard phenol DNA extraction and 23S rDNA-targeted PCR. By using H. influenzae cell suspensions, the limit of detection was determined to be 20,000 CFU per sample (Table 1) .
Lysis by bead beating and sonication. Two hundred-microliter suspensions of S. pyogenes and H. influenzae containing 200,000 to 2 CFU in PBS were beaten with glass beads for 30 s or 1, 2, 3, or 5 min prior to standard DNA isolation and were subjected to 23S rDNA PCR. Bead beating for 1 to 2 min yielded the lowest detection limit for S. pyogenes (a clear-cut band with 20,000 CFU per sample and weak bands in two successive dilutions). A total of 2,000 CFU of H. influenzae yielded a clear-cut band after bead beating for 30 s and a weak one after bead beating for 1 min. Continued bead beating resulted in impaired detection of both bacteria, probably reflecting the progressive degradation of DNA, which seemed to occur more readily for H. influenzae than for S. pyogenes (Fig. 1) .
As for sonication, the optimum sonication time for the detection of S. pyogenes was determined to be 5 min both in the presence and in the absence of glass beads, the lowest limit of detection being 20,000 CFU per sample. Short sonication without glass beads yielded the same detection limit for H. influenzae as phenol-ether extraction without sonication, but the detection limit rose if the sonication period exceeded 3 min. In the presence of glass beads the release of S. pyogenes DNA was further enhanced, but lower numbers (below 200,000 CFU) of H. influenzae cells were not detected at any time point (Fig. 2) .
Comparison of DNA isolation kits. Table 1 shows the detection limits obtained for S. pyogenes, M. avium, and H. influenzae by use of standard phenol-ether extraction and various commercial DNA isolation kits alone and in combination with bead beating and sonication. Also, the prices of the kit reagents and plastic ware per reaction and the hands-on and hands-off times used for the extractions are shown. Among the commercial kits tested, the High Pure kit showed improved detection of S. pyogenes and M. avium after inclusion of the additional bead-beating or sonication steps in the protocol. a Samples were 10-fold dilution series of bacteria in PBS containing 200,000 to 2 CFU and 1 million human mononuclear cells in a volume of 200 l. After extraction, DNA was eluted in 200 l of sterile water or the elution buffer included in the kit, and 5 l was amplified with broad-range bacterial primers. The number of CFU in the most dilute sample producing a clear-cut band on a 1.5% agarose gel in at least two independent extractions was considered the detection limit.
b Single times apply to the total time for the methods that do not include longer hands-off steps. c Prices are for reagents and plastic ware. Plastic ware includes Eppendorf tubes not provided in the kit, aerosol-resistant tips, and the plastic ware used by the MagNA Pure instrument.
Masterpure DNA purification kit without additional lysis steps and the High Pure PCR template purification kit with an additional sonication step were selected for comparison with the standard phenol-ether extraction method (which included no additional lysis steps). Sixty-nine consecutive specimens (12 tissue biopsy specimens [including 3 cardiac valve specimens], 15 synovial fluid specimens, 11 pleural fluid specimens, 10 cerebrospinal fluid specimens, 7 amniotic fluid specimens, 3 pericardial fluid specimens, 1 ascitic fluid specimen, and 10 pus samples) were treated by standard phenol-ether extraction and purified with the Masterpure kit. Of these, 48 samples were negative by the broad-range bacterial PCR after both DNA isolation protocols. Eleven samples were positive for bacterial DNA by both methods, two were positive by the standard method only, and one was positive only by the Masterpure kit (Table 2) . A biopsy specimen from an aortic valve was inhibitory to the PCR after purification with the Masterpure kit, whereas streptococcal DNA was amplified from the phenolpurified half (Table 2, sample 12). A cerebrospinal fluid sample was inhibitory to the PCR after routine purification, as judged by the failure to detect human DNA also after 90 ng was spiked into the sample (7); the aliquot purified with the Masterpure kit was negative by bacterial PCR. Four samples purified with the Masterpure kit yielded weak bands in the PCR and were classified as contaminated on the basis of a weak band from the negative isolation control of the batch. All remained negative by PCR with the phenol-purified aliquot.
A total of 68 specimens (15 biopsy specimens, 9 synovial fluid specimens, 8 pleural fluid specimens, 9 cerebrospinal fluid specimens, 8 amniotic fluid specimens, 3 ascitic fluid specimens, and 16 pus samples from abscesses) were processed by the routine protocol and the High Pure protocol with the FIG. 2. Effect of sonication with and without glass beads on detection of bacteria by 23S rDNA-targeted PCR. Bacterial cell suspensions were treated by the standard proteinase K-phenol-ether DNA-extraction protocol, and 5 l of the DNA was used in PCR. The lysis of bacteria was enhanced by sonication for 1 min (A and B), 5 min (C and D) or 10 min (E and F). The samples on the gels in panels A, C, and E were as follows: lanes 1 to 6, 200,000, 20,000, 2,000, 200, and 20 CFU of S. pyogenes in 200 l of PBS and a negative isolation control with PBS only, respectively; lanes 7 to 12, replicates of the samples in lanes 1 to 6, respectively, with 0.3 g of zirconia beads in each sample. The samples on the gels in panels B, D, and F were as follows: lanes 1 to 6, 200,000, 20,000, 2,000, 200, and 20 CFU of H. influenzae in 200 l of PBS and a negative control with PBS only, respectively; lanes 7 to 12, replicates of the samples in lanes 1 to 6, respectively, with 0.3 g of zirconia beads in each sample. Lanes ϩ, positive control (50 ng of DNA from B. subtilis ATCC 6051); lanes Ϫ, negative reagent control (5 l of a sterile UV-irradiated distilled water as a template). The lanes on both sides of each gel contain a molecular size marker (100-bp DNA ladder; Life Technologies).
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on October 14, 2017 by guest http://jcm.asm.org/ additional sonication step. Forty-eight samples remained negative for bacterial DNA after both DNA isolation procedures. Both aliquots of 11 samples were PCR positive with consistent sequencing results, 3 samples were PCR positive by the phenol purification protocol only, and 4 samples were positive by the High Pure purification protocol only (Table 3) . A cerebrospinal fluid sample was inhibitory to the PCR after routine purification, and a pus sample was inhibitory after purification with the High Pure kit, with both samples being negative for bacterial DNA by PCR with the aliquot prepared by the other method.
DISCUSSION
In the present work we demonstrate that molecular detection of bacteria with resistant cell walls in clinical samples can be enhanced by use of physical cell wall disintegration methods. Furthermore, the amplification of DNA derived from bacteria that are easily lysed is not compromised if the treatments are carefully optimized.
In the early diagnostic applications of PCR, classic phenol extraction was successfully used to prepare DNA for amplification. A major advantage of phenol is that it inactivates microbes very efficiently, including, e.g., spores of Bacillus anthracis, which are very resistant to inactivation by other methods (unpublished observations). Unfortunately, phenol is corrosive and toxic; and ether, which is used to remove it from the samples, is explosive. Although the reagents are inexpensive, the classic organic extraction is relatively laborious and unpractical for the processing of large numbers of samples that arrive in the laboratory at different times during the day. Residual phenol may also inhibit amplification of the extracted DNA.
An array of commercially available DNA isolation systems has been developed to circumvent these drawbacks. Ideally, use of DNA isolation kits offers standardized, quality-controlled reagents with optimized compositions for all steps of the process. However, the kits are often designed for isolation of human DNA from human tissue or microbial DNA from cultivated cells rather than for detection of a minor amount of microbial DNA among an abundance of human DNA. Preliminary tests by use of several commercial DNA isolation kits failed to detect the relatively low numbers of bacterial cells in our experimental setting.
Hendolin et al. (2) demonstrated the problem of finding a DNA isolation procedure for clinical specimens that would produce DNA from both gram-positive and gram-negative bacteria with equal efficiencies. They analyzed middle ear effusions for the presence of H. influenzae, Streptococcus pneumoniae, Alloiococcus otitidis, and Moraxella catarrhalis by multiplex PCR after processing the samples either by the classic phenol-ether method or a modified Qiamp DNA extraction protocol with an additional boiling step in sodium dodecyl sulfate-NaOH-chaotropic salt. The phenol method yielded more positive PCR results (48 of 49 specimens; 98%) than the Qiamp method (20 of 24 specimens; 83%). Interestingly, the proportion of specimens positive for gram-negative bacteria (H. influenzae, M. catarrhalis) was significantly higher (P Ͻ 0.001) among phenol-extracted effusions, while the Qiagen protocol produced a higher proportion of samples positive for gram-positive organisms (S. pneumoniae and A. otitidis) with an equal statistical significance (P Ͻ 0.001).
The cell walls of gram-positive bacteria can be efficiently broken by use of the peptidoglycan-degrading enzymes ly- The similarity comparisons are based on the bacterial 16S rDNA sequences available in the EMBL prokaryote database or the 23S rDNA sequences for those samples for which only 23S rDNA sequencing was successful (phenol-ether-purified aliquot of sample 6, and Masterpure protocol-purified aliquots of samples 2 and 9).
c All samples except the Masterpure protocol-purified aliquot of sample 4 were sequenced by use of version 2.0 of the Big Dye Terminator Cycle Sequencing kit; the Masterpure protocol-purified aliquot of sample 4 was amplified by use of version 3.0 of the kit.
d Samples 5 and 6 were from the same patient. e Sequencing failure was reported if the sequencing signals reported by the instrument were weak (average signal intensities, Ͻ100 relative light units for two or more dyes).
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sozyme and mutanolysin. However, to minimize the number of reagents (and possible sources of bacterial DNA) in the PCR and to find a method equally efficient for cell walls of streptococci, staphylococci, and mycobacteria, we preferred the use of physical disintegration methods, i.e., bead beating and sonication. We aimed at determining a treatment time window that would enhance the release of DNA from difficult-to-lyse bacterial cells without severely compromising the detection of gram-negative organisms. A short bead beating was the most efficient lysis method for this purpose, but use of glass beads in combination with the membrane-formatted DNA purification methods proved difficult, as a small number of beads tended to end up in the purification column with the lysate and block the column. A sonication step was also integrated into the routine work flow more easily than bead beating. The sonicator used in these experiments is originally a washing sonicator; i.e., the sample tubes are placed in a water bath, which mediates the oscillation produced by the ultrasound crystal. As the tubes remain closed during and immediately after the sonication, there is no risk of cross-contamination. The variability of clinical specimen types adds to the complexity of diagnostic bacterial PCR. This is reflected by the difficulty of extrapolating the experimentally determined detection limits to the true sensitivity in finding bacterial DNA in the clinical samples. The only DNA purification kit (Masterpure) which detected bacteria in lower numbers than the standard method without additional lysis treatments (Table 1) did not prove to be superior to the standard method when it was applied to clinical specimens. In comparison to the results obtained by the phenol-ether extraction procedure, the grampositive bacteria in two samples remained unidentified, and those in one sample were not detected from the aliquot purified by the kit. Identifiable bacterial DNA was not detected after Masterpure purification in any sample that remained negative by the standard method. Modification of the downstream steps, i.e., amplification and sequencing reactions, might have improved the performance of this and some other kits, but these steps were not optimized for analysis of the template DNA produced by each purification method. According to our experience, amplification of the same template DNA by use of different enzymes and amplification systems may result in highly variable detection limits (6; unpublished observations). The Masterpure kit is inexpensive in comparison to the other kits tested, rapid, and applicable to an array of adequate sample types, including biological fluids, cells, and fresh and paraffin-embedded tissues. The contamination observed for four samples was probably cross-contamination. As the isolation control of this run was positive and the reagent control was negative, the contamination is likely to have occurred in the DNA isolation process. The run included a sample (Table 2 , sample 7) with a very large amount of bacteria (as judged from the bands on the agarose gel), which could have been a source of cross-contamination. Unfortunately, sequencing was unsuccessful and insufficient quantities of the original samples were left for reextraction to verify this hypothesis. The isolation controls of the other runs remained negative. The similarity comparisons are based on bacterial 16S rDNA sequences available in the EMBL prokaryote database, except for the High-Pure protocol-purified aliquot of sample 11, for which only 23S rDNA sequencing was successful.
c The sample was sequenced by use of version 3.0 of the Big Dye Terminator Cycle Sequencing kit. The previous version (version 2.0) was used for the other samples. d The sample was interpreted to contain several bacteria, as the electropherogram showed strong signals but multiple overlapping peaks in some locations. e Sequencing failure was reported if the sequencing signals reported by the instrument were weak (average signal intensities, Ͻ100 relative light units for two or more dyes).
